# Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)

> **NCT00907478** · PHASE4 · COMPLETED · sponsor: **Amgen** · enrollment: 169 (actual)

## Conditions studied

- Thrombocytopenia
- Idiopathic Thrombocytopenic Purpura

## Interventions

- **BIOLOGICAL:** romiplostim

## Key facts

- **NCT ID:** NCT00907478
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-11
- **Primary completion:** 2014-01-09
- **Final completion:** 2014-01-14
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907478, "Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00907478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*